Lifevantage PE Ratio 2010-2023 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of May 17, 2024 is 11.11.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-17 6.78 29.48
2023-12-31 5.97 $0.23 25.95
2023-09-30 6.38 $0.20 31.91
2023-06-30 4.04 $0.20 20.20
2023-03-31 3.31 $-0.06 0.00
2022-12-31 3.40 $-0.05 0.00
2022-09-30 3.40 $0.04 85.08
2022-06-30 3.92 $0.24 16.33
2022-03-31 4.26 $0.70 6.08
2021-12-31 5.65 $0.73 7.74
2021-09-30 6.05 $0.98 6.18
2021-06-30 6.57 $0.90 7.30
2021-03-31 8.36 $0.81 10.32
2020-12-31 8.33 $0.80 10.42
2020-09-30 10.79 $0.84 12.85
2020-06-30 12.09 $0.79 15.30
2020-03-31 9.21 $0.79 11.66
2019-12-31 13.96 $0.80 17.44
2019-09-30 12.25 $0.56 21.87
2019-06-30 11.60 $0.50 23.21
2019-03-31 12.78 $0.45 28.39
2018-12-31 11.79 $0.45 26.20
2018-09-30 9.82 $0.41 23.96
2018-06-30 5.69 $0.41 13.89
2018-03-31 3.23 $0.21 15.37
2017-12-31 4.26 $0.09 47.28
2017-09-30 3.77 $0.09 41.92
2017-06-30 3.87 $0.11 35.19
2017-03-31 4.80 $0.26 18.46
2016-12-31 7.29 $0.33 22.08
2016-09-30 8.46 $0.42 20.14
2016-06-30 12.16 $0.42 28.95
2016-03-31 8.14 $0.26 31.29
2015-12-31 8.51 $0.26 32.73
2015-09-30 5.07 $0.22 23.04
2015-06-30 3.32 $0.49 6.77
2015-03-31 4.94 $0.63 7.85
2014-12-31 8.14 $0.70 11.62
2014-09-30 7.13 $0.84 8.49
2014-06-30 9.01 $0.70 12.88
2014-03-31 8.20 $0.56 14.64
2013-12-31 10.33 $0.63 16.40
2013-09-30 14.89 $0.42 35.48
2013-06-30 14.52 $0.42 34.58
2013-03-31 14.71 $0.70 21.01
2012-12-31 13.70 $0.14 97.89
2012-09-30 21.46 $0.49 43.81
2012-06-30 17.71 $0.42 42.17
2012-03-31 23.53 $-3.78 0.00
2011-12-31 8.95 $-4.34 0.00
2011-09-30 9.39 $-4.27 0.00
2011-06-30 9.39 $-4.34 0.00
2011-03-31 4.44 $-0.98 0.00
2010-12-31 2.44 $-1.05 0.00
2010-09-30 3.13 $-1.54 0.00
2010-06-30 3.19 $-1.47 0.00
2010-03-31 2.44 $-1.68 0.00
2009-12-31 1.56 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.086B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00